Tel.: 514-340-8204
morris.schweitzer@mcgill.ca

Or contact:
Riesha Melnick
Tel.: 514-340-8204 
Morris Schweitzer, Ph.D., M.D., F.R.C.P. (C)
 
Senior Investigator, Lady Davis Institute
Co-Director, Centre for Cardiovascular Prevention, Jewish General Hospital
Director of the Lipid Research and Management Clinic
Associate Professor, Faculty of Medicine, McGill University
 
 
Morris Schweitzer received his Ph.D. in Steroid Hormone Metabolism from McGill University. He then obtained his M.D. from Memorial University in Newfoundland. He completed his internship and residency in Internal Medicine at the Montreal General Hospital before obtaining a Fellowship in Endocrinology at the Mayo Clinic, where he worked on gonadotropin regulation of ovarian steroid hormone production. He returned to Montreal, to the Jewish General Hospital, where he is now the Co-Director of the Centre for Cardiovascular Prevention, the Director of the Lipid Research and Management Clinic, and an Associate Professor in the Faculty of Medicine at McGill.

Major Research Activities

Dr. Schweitzer is currently involved in laboratory research in the area of matrix metalloproteinase gene expression and activity in abdominal aortic aneurysms, as well as delineating gene mutations in abdominal aortic aneurysms which could be involved in the pathogenesis of vascular disease. A second area of laboratory research deals with identifying and characterizing mutations in the gene for NPC1L1, which affects intestinal cholesterol absorption. He is also active in teaching and patient care.

Recent Publications

Schweitzer, Morris, Benjamin Mitmaker, Daniel Obrand, Nathan Sheiner, Cherrie Abraham, Stevan Dostanic, and Lorraine E. Chalifour. Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms. Canadian Journal of Physiology and Pharmacology 87 (2009): 915-22.

Gottlieb, Bruce, Lorraine E. Chalifour, and Morris Schweitzer. Response to: BAK1 Gene Variation and Abdominal Aortic Aneurysms-Variants are Likely Due to Sequencing of a Processed Gene on Chromosone 20. Human Mutation 31.1 (2010):110-11

Schweitzer, Morris, Benjamin Mitmaker, Daniel Obrand, Nathan Sheiner, Cherrie Abraham, Stevan Dostanic, Melissa Meilleur, Tomoko Sugahara, and Lorraine E. Chalifour. Atorvastatin Modulates Matrix Metalloproteinase Expression, Activity, and Signaling in Abdominal Aortic Aneurysms. Vascular and Endovascular Surgery 44.2 (2010): 116-22.
Snapshot

Dr. Schweitzer is currently involved in laboratory research in the area of matrix metalloproteinase gene expression and activity in abdominal aortic aneurysms.

He is also involved in identifying and characterizing mutations in the gene for NPC1L1 which affects intestinal cholesterol absorption.

 
 
Important Links

 
Support research at the Lady Davis Institute - Jewish General Hospital